Altshuler David's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Feb 28, 2023
- Accession no.
- 0001209191-23-013685
- Filed
- Feb 28, 2023
- Trade date
- Feb 24-27, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions. Open-market sales total $1.22M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Altshuler DavidCIK 0001550395 | Officer (EVP, Global Research and CSO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 24, 2023 | Common Stock | FTax withholdingDisposed | −3,970 | $289.12 | −$1,147,806.4 | 36,276 | Direct | |
| Feb 27, 2023 | Common Stock | SSaleDisposed | −3,636 | $287.23F2,F3 | −$1,044,368.28 | 32,640 | Direct | |
| Feb 27, 2023 | Common Stock | SSaleDisposed | −300 | $288.74F2,F4 | −$86,622 | 32,340 | Direct | |
| Feb 27, 2023 | Common Stock | SSaleDisposed | −302 | $289.60F2,F5 | −$87,459.2 | 32,038 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Dr. Altshuler undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Referenced by the price of 3 transactions in Table I.
- F3
Open market sales reported on this line occurred at a weighted average price of $287.23 (range $286.80 to $287.72).
Referenced by the price of 1 transaction in Table I.
- F4
Open market sales reported on this line occurred at a weighted average price of $288.74 (range $288.42 to $289.37).
Referenced by the price of 1 transaction in Table I.
- F5
Open market sales reported on this line occurred at a weighted average price of $289.60 (range $289.49 to $289.65).
Referenced by the price of 1 transaction in Table I.